Related references
Note: Only part of the references are listed.CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients
Seung-Hyun Kim et al.
PHARMACOGENOMICS (2007)
Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends
Valerie Capra et al.
MEDICINAL RESEARCH REVIEWS (2007)
Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease
W. Berger et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Efficacy and safety of montelukast in adults with asthma and allergic rhinitis
J. Chr. Virchow et al.
RESPIRATORY MEDICINE (2006)
Distribution of specific binding sites for cysteinyl leukotriene 1 receptor antagonist in human nasal mucosa
Hideaki Shirasaki et al.
ACTA OTO-LARYNGOLOGICA (2006)
Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial
DB Price et al.
ALLERGY (2006)
Leukotriene C4 synthase A-444C gene polymorphism in patients with allergic rhinitis
HG Eskandari et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2006)
Determination of structure and transcriptional regulation of CYSLTR1 and an association study with asthma and rhinitis
Jian Zhang et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2006)
Efficacy of a leukotriene receptor antagonist in the treatment of perennial allergic rhinitis
RS Jiang
JOURNAL OF OTOLARYNGOLOGY (2006)
Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics
JS Park et al.
PHARMACOGENETICS AND GENOMICS (2005)
Leukotriene receptor antagonists for allergic rhinitis: A systematic review and meta-analysis
AM Wilson et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis
G Di Lorenzo et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Association between a polymorphism in cysteinyl leukotriene receptor 2 on chromosome 13q14 and atopic asthma
H Fukai et al.
PHARMACOGENETICS (2004)
Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure
YQ Hui et al.
CIRCULATION (2004)
Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice
TC Beller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis
G Philip et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Leukotriene modifier vs inhaled corticosteroid in mild-to- moderate asthma - Clinical and anti-inflammatory effects
DW Perng et al.
CHEST (2004)
Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis
DJ Figueroa et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R
EA Mellor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Effects of zafirlukast on bronchial asthma and allergic rhinitis
G Piatti et al.
PHARMACOLOGICAL RESEARCH (2003)
Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis
S Saengpanich et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2003)
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
DB Price et al.
THORAX (2003)
Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis
AR Sousa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
F Kanniess et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT1 antagonist, pranlukast, in Japanese patients with moderate asthma
K Asano et al.
PHARMACOGENETICS (2002)
Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4
BD Levy et al.
NATURE MEDICINE (2002)
Membrane localization and topology of leukotriene C4 synthase
P Christmas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa
H Shirasaki et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring
G Philip et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses
A Maekawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis
T Pullerits et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Pharmacological differences among CysLT1 receptor antagonists with respect to LTC4 and LTD4 in human lung parenchyma
S Ravasi et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Prostaglandins and leukotrienes: Advances in eicosanoid biology
CD Funk
SCIENCE (2001)
Allergic rhinitis and its impact on asthma
J Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils
H Mita et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2001)
A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma
AM Wilson et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2001)
Pranlukast protects leukotriene C4- and D4-induced epithelial cell impairment of the nasal mucosa in vitro
K Hisamatsu et al.
LIFE SCIENCES (2000)
Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast
AP Sampson et al.
THORAX (2000)
Characterization of the human cysteinyl leukotriene 2 receptor
CE Heise et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT2 receptor
J Takasaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge
W Phipatanakul et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial
EO Meltzer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Share Paper
